Johnston Acquisition Corp. (fka JAQC)

[$hellKing]

Industry Trends Ensure Future Market for Generic Pharmaceuticals

The pharmaceutical industry has and will continue to experience significant and
prosperous changes over the coming years. With an increasing number of large
pharmaceutical companies growing via internal expansion, mergers and company
acquisitions, financial contributions towards clinical trials, drug research, and product development have become internationally common place. The rapid and growing
emphasis on research and development within the industry has stabilized the future
pharmaceutical market–ensuring a rich and diverse product portfolio–and has paved the way for Generic Pharmaceutical companies such as Rafarma.
Future Growth: Trends, Technology, and a Bright Future for Pharmaceuticals

Exciting advances in healthcare science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. As a result, a growing population of elderly citizens (the most sizeable portion of the pharmaceuticals market) has bolstered the demand for pharmaceuticals nationwide. Happily, increased emphasis on healthcare and medicines ensures that this trend will continue into the future.

What particular advantages does this trend provide for Rafarma? As the population of elderly citizens throughout Eastern Europe has grown, so too has economic turmoil stressed the affordability and accessibility of necessary drugs. Russian government mandates requiring physicians use Rafarma products combined with the lower price of generic pharmaceuticals proffers companies such as Rafarma a unique niche within the Eastern European Pharmaceuticals market: Growing demand and a struggling economy equate to increased favorability, from both healthcare providers and individuals, towards companies that provide cheaper products.